USA · Lot 2026·04 · In stock
RETA+
Apothecary-grade retatrutide — triple incretin agonist (GLP-1 / GIP / glucagon), lyophilized and vacuum-sealed. Purity ≥ 99 % verified by HPLC, sterile-filtered, lot-labeled.
Purity
≥ 99%
Verification
HPLC
Form
Lyophilized
01 — Product
Four presentations,
one molecule.
Each vial contains retatrutide lyophilized under inert atmosphere and sealed with a bromobutyl stopper. Reconstitute with Hospira bacteriostatic water for research use.
Your selection
Retatrutide · 24 mg
Vial liofilizado · 24 mg · pureza ≥ 99 %.
Availability
Available
Weight
80 g
Requires reconstitution with bacteriostatic water · Made in USA
02 — Technical sheet
Verified
specifications.
Every lot ships with its Certificate of Analysis (COA). Available on request from support.
Identity
Retatrutide (LY3437943)
CAS
2381089-83-2
Sequence
Modified GLP-1/GIP/glucagon triple-agonist analog
Molecular weight
4731.36 g · mol⁻¹
Molecular formula
C221H343N51O64
Purity
≥ 99.0 % (HPLC)
Form
Lyophilized powder, white to off-white
Vial
Type I borosilicate glass · bromobutyl stopper · aluminum seal
Filling
Inert atmosphere (N₂) · 0.22 µm sterile-filtered
Storage (unreconstituted)
2–8 °C, protect from light
Post-reconstitution stability
≤ 180 days refrigerated · 0.9 % benzyl alcohol
Solubility
Soluble in bacteriostatic water and saline
Origin
EU manufactured · packaged in Miami, USA
03 — Solvent
Bacteriostatic water
Hospira · 30 mL
Solvent required to reconstitute the retatrutide vials. Preserves peptide activity for up to 180 days refrigerated. Preservative: 0.9 % USP benzyl alcohol.
- + Multi-dose 30 mL vial · USP grade
- + 0.9 % benzyl alcohol · bacteriostatic agent
- + Bromobutyl stopper · aluminum seal
- + Suitable for reconstituting lyophilized peptides
Hospira BAC water
Hospira 30 mL
Vial multidosis 30 mL · 0.9 % alcohol bencílico USP. Solvente para reconstitución.
04 — Handling
Clean reconstitution,
step by step.
01
Solvent insertion
Wipe the stopper with 70 % isopropyl. Inject the calculated volume of bacteriostatic water against the vial wall — never a direct stream onto the powder.
02
Gentle dissolution
Roll gently between your hands until clarified. Do not shake. The solution should appear clear and particle-free.
03
Storage
Refrigerate 2–8 °C, protected from light. Stable up to 30 days with bacteriostatic. Label with the reconstitution date.
⚠ Procedure described for in vitro research only. Not for human or veterinary use.
05 — Quality
Every lot, full
traceability.
A
HPLC verification
Every lot is assayed by reverse-phase HPLC. Purity ≥ 99 % or it isn't released. COA available on request with lot number and analyst signature.
B
Lyophilized · no cold chain
Ships as powder in a vacuum-sealed vial under inert atmosphere. Room-temp stable in transit — no gel pack, no insulated box. You activate the dose on arrival by reconstituting with bacteriostatic water right before use.
C
Discreet packaging
Outer carton unbranded with no mention of the contents. Internal handling instructions. Recipient confidentiality.
06 — Questions
What you
should know.
Retatrutide (LY3437943) is a triple-agonist peptide analog of the GLP-1, GIP and glucagon receptors, in advanced clinical research by Eli Lilly. We distribute it as a reference compound for in vitro research.
Research-grade peptides · Made in Miami, USA